Guo, Yu; Zhang, Guangshun; Yang, Qi; Xie, Xiaowei; Lu, Yang; Cheng, Xuelian; Wang, Hui; Liang, Jingxi; Tang, Jielin; Gao, Yuxin; Shang, Hang; Dai, Jun; Shi, Yongxia; Zhou, Jiaxi; Zhou, Jun; Guo, Hangtian; Yang, Haitao; Qi, Jianwei; Liu, Lijun; Ma, Shihui; Zhang, Biao; Huo, Qianyu; Xie, Yi; Wu, Junping; Dong, Fang; Zhang, Song; Lou, Zhiyong; Gao, Yan; Song, Zidan; Wang, Wenming; Sun, Zixian; Yang, Xiaoming; Xiong, Dongsheng; Liu, Fengjiang; Chen, Xinwen; Zhu, Ping; Wang, Ximo; Cheng, Tao; Rao, Zihe

Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome? (vol 13, 846323, 2022)

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-06-090

OAAI

Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection

IMMUNITY

IF26.3

2023-06-0118

OAAI

Wang, Hong; Liu, Cuicui; Xie, Xiaowei; Niu, Mingming; Wang, Yingrui; Cheng, Xuelian; Zhang, Biao; Zhang, Dong; Liu, Mengyao; Sun, Rui; Ma, Yezi; Ma, Shihui; Wang, Huijun; Zhu, Guoqing; Lu, Yang; Huang, Baiming; Su, Pei; Chen, Xiaoyuan; Zhao, Jingjing; Wang, Hongtao; Shen, Long; Fu, Lixia; Huang, Qianqian; Yang, Yang; Wang, He; Wu, Chunlong; Ge, Weigang; Chen, Chen; Huo, Qianyu; Wang, Qingping; Wang, Ying; Geng, Li; Xie, Yan; Xie, Yi; Liu, Lijun; Qi, Jianwei; Chen, Huaiyong; Wu, Junping; Jiang, Erlie; Jiang, Wentao; Wang, Ximo; Shen, Zhongyang; Guo, Tiannan; Zhou, Jiaxi; Zhu, Ping; Cheng, Tao

Real-World Effectiveness of Primary Series and Booster Doses of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2 Variant Infection in China: A Retrospective Cohort Study

针对Omicron BA.2变体感染的初级系列和加强剂量的冠状病毒疾病2019灭活疫苗的真实世界有效性: 一项回顾性队列研究

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2023-04-0316

OAAI

Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2023-01-2119

Hou, Ling; Huang, Ke; Gong, Chunxiu; Luo, Feihong; Wei, Haiyan; Liang, Liyang; Du, Hongwei; Zhang, Jianping; Zhong, Yan; Chen, Ruimin; Chen, Xinran; Pan, Jiayan; Jin, Xianjiang; Zeng, Ting; Liao, Wei; Liu, Deyun; Lan, Dan; Zhu, Shunye; Dong, Zhiya; Ma, Huamei; Yang, Yu; Xiong, Feng; Lu, Ping; Cheng, Shengquan; Gu, Xuefan; Jin, Runming; Liu, Yu; Wu, Jinzhun; Xu, Xu; Chen, Linqi; Dong, Qin; Pan, Hui; Su, Zhe; Liu, Lijun; Luo, Xiaoming; Ni, Shining; Chen, Zhihong; Hu, Yuhua; Wang, Chunlin; Liu, Jing; Liu, Li; Lu, Biao; Wang, Xinli; Wang, Yunfeng; Yang, Fan; Zhang, Manyan; Cao, Lizhi; Liu, GeLi; Yao, Hui; Zhan, Yaqin; Dai, Mingjuan; Li, Guimei; Li, Li; Liu, Yanjie; Wang, Kan; Xiao, Yanfeng; Zhang, Xingxing; Dong, Junhua; Gu, Zaiyan; Ying, Lirong; Huang, Feng; Liu, Yanling; Liu, Zheng; Ye, Jin; Zhao, Dongmei; Hu, Xu; Jiang, Zhihong; Ye, Kan; Zhu, Hong; Chen, Shaoke; Chen, Xiaobo; Wan, Naijun; Xu, Zhuangjian; Yin, Qingjin; Zhang, Hongxiao; Huang, Xiaodong; Yin, Jianying; Zhang, Huifeng; Li, Pin; Yin, Ping; Fu, Junfen; Luo, XiaoPing

Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells

薯蓣皂苷抑制EGFR介导的Survivin表达促进口腔鳞癌细胞凋亡

JOURNAL OF CANCER

IF3.2

2023-01-015

OAAI

Icotinib, an EGFR tyrosine kinase inhibitor, as adjuvant therapy for patients with stage IIA-IIIA EGFR-mutant non-small-cell lung adenocarcinoma: a multicenter, open-label, single-arm, phase II study (ICAPE)

埃克替尼，一种EGFR酪氨酸激酶抑制剂，作为iia-iiia期EGFR突变非小细胞肺腺癌患者的辅助治疗: 一项多中心，开放标签，单臂，II期研究 (ICAPE)

INVESTIGATIONAL NEW DRUGS

IF2.7

2022-11-101

PRE